Document Detail

Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.
MedLine Citation:
PMID:  17414047     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To investigate the effects of valacyclovir and prednisolone in comparison with those of placebo and prednisolone for the treatment of Bell's palsy, excluding zoster sine herpete. STUDY DESIGN: Prospective, multicenter, randomized placebo-controlled study. SETTING: Six academic tertiary referral centers. PATIENTS: Ultimately, 221 patients with Bell's palsy who were treated within 7 days of the onset. Serological and polymerase chain reaction examinations were performed to distinguish Bell's palsy from zoster sine herpete. INTERVENTION: The patients were treated with either valacyclovir (dosage, 1,000 mg/d for 5 days) plus prednisolone (VP [n = 114]) or placebo plus prednisolone (PP [n = 107]) administered orally. MAIN OUTCOME MEASURE: Recovery from the palsy was defined as a score higher than 36 using Yanagihara 40-point scoring system without facial contracture or synkinesis. The patients were followed up until complete recovery occurred or for more than 6 months in cases with a poor prognosis. RESULTS: The overall rate of patient recovery among those treated with VP (96.5%) was significantly better (p < 0.05) than the rate among those treated with PP (89.7%). The rate of patient recovery was also analyzed by classifying the initial severity of facial palsy. In cases of complete or severe palsy, the rates of patients treated with VP and PP who recovered were 95.7% (n = 92) and 86.6% (n = 82), respectively; the recovery rate for treatment with VP was significantly better than that with PP (p < 0.05). CONCLUSION: The valacyclovir and prednisolone therapy was more effective in treating Bell's palsy, excluding zoster sine herpete, than the conventional prednisolone therapy. To our knowledge, this is the first controlled study of an antiviral agent in the treatment of a sufficient number of Bell's palsy cases based on an etiologic background.
Naohito Hato; Hiroyuki Yamada; Hisashi Kohno; Shuichi Matsumoto; Nobumitsu Honda; Kiyofumi Gyo; Satoshi Fukuda; Yasushi Furuta; Fumio Ohtani; Hiroshi Aizawa; Masaru Aoyagi; Hiroo Inamura; Tsutomu Nakashima; Seiichi Nakata; Shingo Murakami; Jun Kiguchi; Koji Yamano; Taizo Takeda; Masashi Hamada; Kazuhiro Yamakawa
Related Documents :
24200407 - Recovery of motor deficit accompanying sciatica-subgroup analysis of a randomized con...
23698497 - Endoscopic treatment of neoplastic enteral obstruction by means of self-expanding metal...
23544687 - Comprehensive arthroscopic management (cam) procedure: clinical results of a joint-pres...
23141817 - Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (d...
23676807 - Transanal haemorrhoidal dearterialisation with mucopexy versus stapler haemorrhoidopexy...
23164737 - First experience of 3d rotational angiography fusion with navx electroanatomical mappin...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology     Volume:  28     ISSN:  1531-7129     ISO Abbreviation:  Otol. Neurotol.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-06     Completed Date:  2007-06-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100961504     Medline TA:  Otol Neurotol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  408-13     Citation Subset:  IM    
Department of Otolaryngology, Ehime University School of Medicine, Toon City, Ehime, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acyclovir / analogs & derivatives*,  therapeutic use
Aged, 80 and over
Antiviral Agents / therapeutic use*
Bell Palsy / diagnosis,  drug therapy*
Diagnosis, Differential
Drug Administration Schedule
Drug Therapy, Combination
Middle Aged
Prednisolone / therapeutic use*
Severity of Illness Index
Valine / analogs & derivatives*,  therapeutic use
Reg. No./Substance:
0/Antiviral Agents; 124832-27-5/valacyclovir; 50-24-8/Prednisolone; 59277-89-3/Acyclovir; 7004-03-7/Valine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Facial paralysis associated with cholesteatoma: a review of 13 cases.
Next Document:  The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus.